Navigation Links
Reducing the damage of a heart attack
Date:12/15/2008

NEW YORK (Dec. 15, 2008) -- In the aftermath of a heart attack, the body's own defenses may contribute to future heart failure. Authors of a new study believe they have identified a protein that plays an important role in a process that replaces dead heart muscle with stiffening scar tissue. The researchers are hopeful that the findings will lead to the development of new therapies to prevent this damage.

"The body tries to fix the injury to the heart muscle by depositing the fibers, but this causes a greater problem," says Dr. Thomas Sato, co-senior author of the study and the Joseph C. Hinsey Professor in Cell and Developmental Biology at Weill Cornell Medical College in New York City. "This process, called fibrosis, causes the heart to become like steel, unable to contract and pump blood throughout the body. The result can be fatal."

Myocardial infarction causes 13 percent of deaths worldwide and is the leading cause of death in industrialized countries.

The researchers' promising findings were published online, Dec. 14, in Nature Cell Biology and will be featured in the upcoming January issue. Due to the findings' significance, the journal has selected the study as an issue highlight.

"Treatments for fibrosis in the heart are relatively limited, making it important to develop new and novel approaches to limit fibrosis," explains Dr. Craig Basson, co-author of the study, the Gladys and Roland Harriman Professor of Medicine and director of the Center for Molecular Cardiology at Weill Cornell Medical College, and attending physician at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

Dr. Sato and his team removed from a mouse's genome a gene called Sfrp2, stopping the mice from producing the protein sFRP2. They found that there was less scar tissue formed in the hearts of mice without the gene, compared to normal mice that still had the gene within their DNA.

The experimental mice also ha
'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Page: 1 2

Related biology news :

1. Pollinator decline not reducing crop yields just yet
2. Providing toilets, safe water is top route to reducing world poverty: UN University
3. Forest peoples rights key to reducing emissions from deforestation
4. Action needed now for Minnesota to reach goals in reducing greenhouse gas emissions by 2015
5. Scientists demonstrate means of reducing Alzheimers-like plaques in fly brain
6. The benefits of green tea in reducing an important risk factor for heart disease
7. New research offers prioritization plan for reducing nutrient pollution in feeder streams
8. Corazonas Foods and Brandeis University partner to create cholesterol-reducing snacks
9. UC Davis team refines cancer treatments to reduce potential nerve damage
10. Single adult stem cell can self renew, repair tissue damage in live mammal
11. Mammals can be stimulated to regrow damaged inner retina nerve cells

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...n of flax shives, and generated from Brassica car...hich engulf fields in spring, can be used to produ...ies carried out by Spanish and Dutch researchers a...able Energy Reviews . , "These studies evaluate, ...n of bioethanol from two, as yet unexploited sourc...
(Date:11/19/2009)... at the end of the last ice age, North America,s v...onic creatures as mammoths, mastodons, camels, hor...precipitous slide to extinction. , And when thei...sity of large animals equaled or surpassed Africa,...ntirely novel ecosystem emerged as broadleaved tre...
(Date:11/19/2009)...year, multi-institutional effort co-led by three C...minated today in publication of a landmark series ...precedented detail the DNA sequence of maize ( Zea...by North American consumers, is one of the world,s...ultural crop grown in the United States, represent...
Breaking Biology News(10 mins):Flax and yellow flowers can produce bioethanol 2After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases 28AASLD 29 Annual Meeting 60479 1Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases 28AASLD 29 Annual Meeting 60479 2Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases 28AASLD 29 Annual Meeting 60479 3Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases 28AASLD 29 Annual Meeting 60479 4Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases 28AASLD 29 Annual Meeting 60479 5Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases 28AASLD 29 Annual Meeting 60479 6Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases 28AASLD 29 Annual Meeting 60479 7Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases 28AASLD 29 Annual Meeting 60479 8Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases 28AASLD 29 Annual Meeting 60479 9Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases 28AASLD 29 Annual Meeting 60479 10Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases 28AASLD 29 Annual Meeting 60479 11Bacteria launch a shield to resist attack 10598 1Bacteria launch a shield to resist attack 10598 2Virulent Strain of MRSA Resists Treatment 60476 1Virulent Strain of MRSA Resists Treatment 60476 2
...ypical of their species, the first known example a...restrial mammal. The discovery, reported in today,...rning is important for maintaining individual soci...eunite over time, like dolphins and whales, some b...ust for Elephants in Kenya, the Woods Hole Oceanog...
... i.e., integrated chemical and biochemical laborat...An essential prerequisite for such labs are approp...y small amounts of liquids and chemical reagents. ... fabricated by available photolithographic methods... microcompartments and, thus, provide a new route ...
...em cells in the absence of contaminated animal pro...ornia, San Diego (UCSD) School of Medicine researc...ia. , Published in the April 2005 issue of the jou...ulture media enriched by a human protein called ac... stem cells in a continuous undifferentiated state...
Other Biology News:Elephants imitate sounds as a form of social communication 2Open microfluidic and nanofluidic systems 2Open microfluidic and nanofluidic systems 3Open microfluidic and nanofluidic systems 4UCSD researchers maintain stem cells without contaminated animal feeder layers 2
(Date:11/19/2009)... VIENNA, Austria, November 19 AFFi...on one product candidate at an unexpectedly early,...s planned to enter into,Phase II clinical trial ea...ely follows the completion of two Phase I trials w...d its fast decision on the first interim,analysis ...
(Date:11/18/2009).... Imagine a polka-dotted postage stamp that can s...y changing colors. , As reported in the Sept. 13...Suslick and his team at the University of Illinois... detection of toxic industrial chemicals (TICs) th...isualizing odors. This sensor array could be usef...
(Date:11/18/2009)... Calif., Nov. 18 Masim...try(TM) and Measure-Through Motion and Low-Perfusi...ce-based Uni.H.A., one of the largest healthcare G... signed a multi-year purchasing agreement for "gol...he agreement offers preferred contract pricing to ...
(Date:11/18/2009)... Promega Corporation and SwitchGear Genomic...rotein interactions. , Ma...a Corporation and SwitchGear Genomics announce a n...tions. Results of a study using the HaloCHIP&trade...strate the ability to correlate DNA binding events...
Breaking Biology Technology:AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2
...l Xyrem(R) Net Sales Increase 34 Percent ...PALO ALTO, Calif., Feb. 13 Jazz,Pharmaceuticals, ...sults for,the fourth quarter and full year ended D... ended December 31, 2007 were $15.5,million, compa...r 31, 2006.,Total revenues for the year ended Dece...
... Feb. 13 Rocky Mountain Biosystems, Inc.(R),(RMBI...nounced receipt of a,grant award of approximately ...e of Allergy and Infectious Diseases at the Nation...Administered Vaccination Electromechanical,(SAVE) ... of a pandemic,this needle-free system could be ra...
..., Mass., Feb. 13 Inverness Medical,Innovations (A...nounced,acquisition of BBI Holdings Plc was succes... in the United Kingdom, specializes in the develop...tests and has achieved a,global reputation for man...al purchase price consisted of cash of approximate...
Other Biology Technology:Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results 2Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results 3Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results 4Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results 5Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results 6Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results 7Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results 8Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results 9NIH Funds Vaccine Research for Needle-free and Self-Administered Protection Against Pandemic Influenza 2
DHFR-1 FP-1 Forward Sequencing Primer from EPICENTRE Biotechnologies
Rabbit Anti-Raf-1, phospho (Ser338 / Tyr341) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-VEGF Receptor 1 Monoclonal Antibody, Unconjugated, Clone Flt-1 / EWC from Abcam
Rabbit Anti-MMP-1 / 8 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: